The consensus IFR is generally in a lower range, from 0.2% to 1%. Here is meta analysis that pegs the range from about 0.5-1%. https://www.medrxiv.org/content/10.1101/2020.05.03.20089854v...

But note this includes estimates from February, with a lot more unknowns, and fails to take into account improved treatments (Remdisivir, Plasma, ventilator use improvements, etc).

Moving forward, given treatment improvements, I think a consensus IFR range would likely be 0.1% to 0.7%.